127 related articles for article (PubMed ID: 37391028)
1. Uncovering CNS access of lipidated exendin-4 analogues by quantitative whole-brain 3D light sheet imaging.
Skovbjerg G; Roostalu U; Salinas CG; Skytte JL; Perens J; Clemmensen C; Elster L; Frich CK; Hansen HH; Hecksher-Sørensen J
Neuropharmacology; 2023 Nov; 238():109637. PubMed ID: 37391028
[TBL] [Abstract][Full Text] [Related]
2. The major determinant of exendin-4/glucagon-like peptide 1 differential affinity at the rat glucagon-like peptide 1 receptor N-terminal domain is a hydrogen bond from SER-32 of exendin-4.
Mann RJ; Nasr NE; Sinfield JK; Paci E; Donnelly D
Br J Pharmacol; 2010 Aug; 160(8):1973-84. PubMed ID: 20649595
[TBL] [Abstract][Full Text] [Related]
3. Role of lateral septum glucagon-like peptide 1 receptors in food intake.
Terrill SJ; Jackson CM; Greene HE; Lilly N; Maske CB; Vallejo S; Williams DL
Am J Physiol Regul Integr Comp Physiol; 2016 Jul; 311(1):R124-32. PubMed ID: 27194565
[TBL] [Abstract][Full Text] [Related]
4. Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity.
Cabou C; Campistron G; Marsollier N; Leloup C; Cruciani-Guglielmacci C; Pénicaud L; Drucker DJ; Magnan C; Burcelin R
Diabetes; 2008 Oct; 57(10):2577-87. PubMed ID: 18633100
[TBL] [Abstract][Full Text] [Related]
5. Differences in the central anorectic effects of glucagon-like peptide-1 and exendin-4 in rats.
Barrera JG; D'Alessio DA; Drucker DJ; Woods SC; Seeley RJ
Diabetes; 2009 Dec; 58(12):2820-7. PubMed ID: 19741167
[TBL] [Abstract][Full Text] [Related]
6. A vitamin B12 conjugate of exendin-4 improves glucose tolerance without associated nausea or hypophagia in rodents.
Mietlicki-Baase EG; Liberini CG; Workinger JL; Bonaccorso RL; Borner T; Reiner DJ; Koch-Laskowski K; McGrath LE; Lhamo R; Stein LM; De Jonghe BC; Holz GG; Roth CL; Doyle RP; Hayes MR
Diabetes Obes Metab; 2018 May; 20(5):1223-1234. PubMed ID: 29327400
[TBL] [Abstract][Full Text] [Related]
7. Association of glucagon-like peptide-1 receptor-targeted imaging probe with in vivo glucagon-like peptide-1 receptor agonist glucose-lowering effects.
Murakami T; Fujimoto H; Fujita N; Hamamatsu K; Yabe D; Inagaki N
J Diabetes Investig; 2020 Nov; 11(6):1448-1456. PubMed ID: 32323451
[TBL] [Abstract][Full Text] [Related]
8. Oleoylethanolamide modulates glucagon-like peptide-1 receptor agonist signaling and enhances exendin-4-mediated weight loss in obese mice.
Brown JD; McAnally D; Ayala JE; Burmeister MA; Morfa C; Smith L; Ayala JE
Am J Physiol Regul Integr Comp Physiol; 2018 Oct; 315(4):R595-R608. PubMed ID: 29949410
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide-1 receptors and sexual behaviors in male mice.
Vestlund J; Jerlhag E
Psychoneuroendocrinology; 2020 Jul; 117():104687. PubMed ID: 32388229
[TBL] [Abstract][Full Text] [Related]
10. The glucagon-like peptide-1 receptor in the ventromedial hypothalamus reduces short-term food intake in male mice by regulating nutrient sensor activity.
Burmeister MA; Brown JD; Ayala JE; Stoffers DA; Sandoval DA; Seeley RJ; Ayala JE
Am J Physiol Endocrinol Metab; 2017 Dec; 313(6):E651-E662. PubMed ID: 28811293
[TBL] [Abstract][Full Text] [Related]
11. Differential structural properties of GLP-1 and exendin-4 determine their relative affinity for the GLP-1 receptor N-terminal extracellular domain.
Runge S; Schimmer S; Oschmann J; Schiødt CB; Knudsen SM; Jeppesen CB; Madsen K; Lau J; Thøgersen H; Rudolph R
Biochemistry; 2007 May; 46(19):5830-40. PubMed ID: 17444618
[TBL] [Abstract][Full Text] [Related]
12. Self-inducible secretion of glucagon-like peptide-1 (GLP-1) that allows MIN6 cells to maintain insulin secretion and insure cell survival.
Nakashima K; Shimoda M; Hamamoto S; Tatsumi F; Hirukawa H; Tawaramoto K; Kanda Y; Kaku K
Mol Cell Endocrinol; 2012 Feb; 349(2):281-8. PubMed ID: 22108438
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide-1 receptors within the nucleus of the solitary tract regulate alcohol-mediated behaviors in rodents.
Vallöf D; Vestlund J; Jerlhag E
Neuropharmacology; 2019 May; 149():124-132. PubMed ID: 30772374
[TBL] [Abstract][Full Text] [Related]
14. Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice.
Rieg T; Gerasimova M; Murray F; Masuda T; Tang T; Rose M; Drucker DJ; Vallon V
Am J Physiol Renal Physiol; 2012 Oct; 303(7):F963-71. PubMed ID: 22832924
[TBL] [Abstract][Full Text] [Related]
15. The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors.
Dickson SL; Shirazi RH; Hansson C; Bergquist F; Nissbrandt H; Skibicka KP
J Neurosci; 2012 Apr; 32(14):4812-20. PubMed ID: 22492036
[TBL] [Abstract][Full Text] [Related]
16. Endogenous Activation of Glucagon-Like Peptide-1 Receptor Contributes to Blood Pressure Control: Role of Proximal Tubule Na
Martins FL; Bailey MA; Girardi ACC
Hypertension; 2020 Sep; 76(3):839-848. PubMed ID: 32755467
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Optimization, and Biological Evaluation of Corrinated Conjugates of the GLP-1R Agonist Exendin-4.
Tinsley IC; Borner T; Swanson ML; Chepurny OG; Doebley SA; Kamat V; Sweet IR; Holz GG; Hayes MR; De Jonghe BC; Doyle RP
J Med Chem; 2021 Mar; 64(6):3479-3492. PubMed ID: 33677970
[TBL] [Abstract][Full Text] [Related]
18. Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice.
Talsania T; Anini Y; Siu S; Drucker DJ; Brubaker PL
Endocrinology; 2005 Sep; 146(9):3748-56. PubMed ID: 15932924
[TBL] [Abstract][Full Text] [Related]
19. Exendin-4, a glucagon-like peptide-1 analogue, accelerates diabetic wound healing.
Roan JN; Cheng HN; Young CC; Lee CJ; Yeh ML; Luo CY; Tsai YS; Lam CF
J Surg Res; 2017 Feb; 208():93-103. PubMed ID: 27993221
[TBL] [Abstract][Full Text] [Related]
20. Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.
Kanoski SE; Fortin SM; Arnold M; Grill HJ; Hayes MR
Endocrinology; 2011 Aug; 152(8):3103-12. PubMed ID: 21693680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
